跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,903 条关于
“CHO-GS”
全部
5,903
临床试验
2,553
药物
1,244
机构
1,415
资讯
691
去年
Aragen to Launch GMP Biologics Manufacturing in India with Advanced Fed-Batch Platform
5个月前
Thermo Fisher Scientific Launches Next-Generation Cell Line Development Platform to Accelerate Biologics Manufacturing
去年
Asimov Expands Strategic Partnerships to Accelerate Biologics Development Through CHO Edge Platform
上个月
Kyungdong Pharmaceutical and Asimov Complete AI-Driven Cell Line Development for Next-Generation Biosimilar Antibody
6个月前
Asimov Partners with Score Pharma to Develop Enhanced Anti-HER2 Antibody Therapeutics for Breast Cancer
去年
Nurix and Gilead's IRAK4 Degrader GS-6791 Shows Promise for Inflammatory Skin Diseases in Preclinical Studies
3个月前
Lonza Launches Enhanced DNA-to-IND Programme with GS Ori-Go Vector Technology to Accelerate Biologics Development
去年
FDA Clears IND for Nurix and Gilead's Novel IRAK4 Degrader GS-6791/NX-0479 for Inflammatory Conditions
去年
GS-441524 Now Available in the US for Feline Infectious Peritonitis Treatment
去年
CHO Plus Secures U.S. Patent for Engineered Yeast Cell Technology to Boost Protein Production
第 1 页,共 70 页
上一页
下一页